| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.001 |